Literature DB >> 21447945

Probing dry-weight improves left ventricular mass index.

Rajiv Agarwal1, J Michael Bouldin, Robert P Light, Ashok Garg.   

Abstract

BACKGROUND: Although probing dry-weight improves blood pressure control, its effect on echocardiographic left ventricular mass index (LVMI) is unknown.
METHODS: Shortly following dialysis, 292 echocardiograms in 150 patients participating in the DRIP trial were obtained at baseline and longitudinally every 4 weeks on 2 occasions.
RESULTS: At baseline, LVMI was 136.3 g/m(2) in the control group and 138.7 g/m(2) in the ultrafiltration group (p > 0.2 for difference). The change from baseline in LVMI in the control group was +3.5 g/m(2) at 4 weeks and +0.3 g/m(2) at 8 weeks (p > 0.2 for both changes). The change from baseline in LVMI in the ultrafiltration group was -7.4 g/m(2) at 4 weeks (p = 0.005) and -6.3 g/m(2) at 8 weeks (p = 0.045). With ultrafiltration, the change in LVMI diameter was -10.9 g/m(2) more compared to the control group at 4 weeks (p = 0.012) and -6.6 g/m(2) more compared to the control group at 8 weeks (p = 0.21). The reduction in interdialytic ambulatory blood pressure was also greater in response to probing dry-weight in those in the top half of LVMI at baseline (p = 0.02 for interaction effect at week 8).
CONCLUSION: LVMI, an important determinant of prognosis among long-term dialysis patients, is responsive to probing dry-weight.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 21447945      PMCID: PMC3078237          DOI: 10.1159/000326235

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  27 in total

1.  Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis.

Authors:  Christopher T Chan; John S Floras; Judith A Miller; Robert M A Richardson; Andreas Pierratos
Journal:  Kidney Int       Date:  2002-06       Impact factor: 10.612

2.  Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects.

Authors:  G Cannella; E Paoletti; R Delfino; G Peloso; D Rolla; S Molinari
Journal:  Am J Kidney Dis       Date:  1997-11       Impact factor: 8.860

3.  Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study.

Authors:  Gérard M London; Bruno Pannier; Alain P Guerin; Jacques Blacher; Sylvain J Marchais; Bernadette Darne; Fabien Metivier; Hassan Adda; Michel E Safar
Journal:  J Am Soc Nephrol       Date:  2001-12       Impact factor: 10.121

4.  Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy.

Authors:  G P Aurigemma; K H Silver; M A Priest; W H Gaasch
Journal:  J Am Coll Cardiol       Date:  1995-07       Impact factor: 24.094

5.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

6.  Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors.

Authors:  Ernesto Paoletti; Paolo Cassottana; Diego Bellino; Claudia Specchia; Piergiorgio Messa; Giuseppe Cannella
Journal:  Am J Kidney Dis       Date:  2002-10       Impact factor: 8.860

7.  Impact of volume control on left ventricular hypertrophy in dialysis patients.

Authors:  Mehmet Ozkahya; Huseyin Toz; Filiz Qzerkan; Soner Duman; Ercan Ok; Ali Basci; Evert J Dorhout Mees
Journal:  J Nephrol       Date:  2002 Nov-Dec       Impact factor: 3.902

8.  Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention.

Authors:  A Levin; J Singer; C R Thompson; H Ross; M Lewis
Journal:  Am J Kidney Dis       Date:  1996-03       Impact factor: 8.860

9.  Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial.

Authors:  Rajiv Agarwal; Pooneh Alborzi; Sangeetha Satyan; Robert P Light
Journal:  Hypertension       Date:  2009-01-19       Impact factor: 10.190

10.  Effects of early and late intervention with epoetin alpha on left ventricular mass among patients with chronic kidney disease (stage 3 or 4): results of a randomized clinical trial.

Authors:  Simon D Roger; Lawrence P McMahon; Anthony Clarkson; Alex Disney; David Harris; Carmel Hawley; Helen Healy; Peter Kerr; Kelvin Lynn; Alan Parnham; Roess Pascoe; David Voss; Robert Walker; Adeera Levin
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

View more
  11 in total

1.  Interdialytic weight gain in oligoanuric children and adolescents on chronic hemodialysis.

Authors:  Fabio Paglialonga; Silvia Consolo; Maria Albina Galli; Sara Testa; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2014-11-15       Impact factor: 3.714

Review 2.  Setting the dry weight and its cardiovascular implications.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Semin Dial       Date:  2017-06-30       Impact factor: 3.455

3.  Usefulness of US imaging in overhydrated nephropathic patients.

Authors:  Michele Prencipe; Antonio Granata; Alessandro D'Amelio; Giulia Romano; Filippo Aucella; Fulvio Fiorini
Journal:  J Ultrasound       Date:  2014-12-13

Review 4.  Evaluation and Treatment of Hypertension in End-Stage Renal Disease Patients on Hemodialysis.

Authors:  Peter Noel Van Buren
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

5.  The first hour refill index: a promising marker of volume overload in children and young adults on chronic hemodialysis.

Authors:  Fabio Paglialonga; Silvia Consolo; Alberto Edefonti; Giovanni Montini
Journal:  Pediatr Nephrol       Date:  2018-03-01       Impact factor: 3.714

Review 6.  The controversies of diagnosing and treating hypertension among hemodialysis patients.

Authors:  Rajiv Agarwal
Journal:  Semin Dial       Date:  2012-06-11       Impact factor: 3.455

Review 7.  Antihypertensive Agents in the Dialysis Patient.

Authors:  Michelle A Fravel; Elizabeth Bald; Mony Fraer
Journal:  Curr Hypertens Rep       Date:  2019-01-18       Impact factor: 5.369

8.  The interdialytic weight gain: a simple marker of left ventricular hypertrophy in children on chronic haemodialysis.

Authors:  Michael Fischbach; Ariane Zaloszyc; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2015-03-24       Impact factor: 3.714

Review 9.  Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

Review 10.  Assessment and management of hypertension in patients on dialysis.

Authors:  Rajiv Agarwal; Joseph Flynn; Velvie Pogue; Mahboob Rahman; Efrain Reisin; Matthew R Weir
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.